Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „inducer“
Suchtreffer
Begriffe & Kennungen
Balversa · 4.5 · Strong or moderate CYP3A4 inducers Co-administration with carbamazepine, a strong CYP3A4 and weak CYP2C9 induc
Eintrag öffnenBaraclude · 4.5 · Entecavir is not a substrate, an inducer or an inhibitor of cytochrome P450 (CYP450) enzymes (see section 5.2)
Eintrag öffnenBaraclude · 4.5 · Entecavir is not a substrate, an inducer or an inhibitor of cytochrome P450 (CYP450) enzymes (see section 5.2)
Eintrag öffnenBesponsa · 4.5 · Based on in vitro data, coadministration of inotuzumab ozogamicin with inhibitors or inducers of cytochrome P4
Eintrag öffnenBetmiga · 4.5 · Effect of enzyme inducers Substances that are inducers of CYP3A or P-gp decrease the plasma concentrations of
Eintrag öffnenBetmiga · 4.5 · Effect of enzyme inducers Substances that are inducers of CYP3A or P-gp decrease the plasma concentrations of
Eintrag öffnenBiktarvy · 4.5 · Bictegravir is not an inhibitor or inducer of CYP in vivo.
Eintrag öffnenBiktarvy · 4.5 · Tenofovir alafenamide is not an inhibitor or inducer of CYP3A in vivo.
Eintrag öffnenBortezomib Accord · 4.5 · A drug-drug interaction study assessing the effect of rifampicin, a potent CYP3A4 inducer, on the pharmacokine
Eintrag öffnenBortezomib Accord · 4.5 · A drug-drug interaction study assessing the effect of rifampicin, a potent CYP3A4 inducer, on the pharmacokine
Eintrag öffnenBortezomib Accord · 4.5 · In the same drug-drug interaction study assessing the effect of dexamethasone, a weaker CYP3A4 inducer, on the
Eintrag öffnenBortezomib Accord · 4.5 · In the same drug-drug interaction study assessing the effect of dexamethasone, a weaker CYP3A4 inducer, on the
Eintrag öffnenBosulif · 4.5 · CYP3A inducers The concomitant use of bosutinib with strong CYP3A inducers (including, but not limited to carb
Eintrag öffnenBosulif · 4.5 · Caution is warranted if mild CYP3A inducers are used concomitantly with bosutinib.
Eintrag öffnenBraftovi · 4.5 · CYP substrates Encorafenib is a strong inducer of CYP3A4. Concomitant use with agents that are substrates of C
Eintrag öffnenBraftovi · 4.5 · CYP3A4 inducers Co-administration of encorafenib with a strong CYP3A4 inducer was not assessed in a clinical s
Eintrag öffnenBrilique · 4.5 · 51 CYP3A inducers may decrease exposure and efficacy of ticagrelor, therefore, their concomitant use with tica
Eintrag öffnenBrilique · 4.5 · CYP3A inducers Co-administration of rifampicin with ticagrelor decreased ticagrelor Cmax and AUC by 73% and 86
Eintrag öffnenBrilique · 4.5 · CYP3A inducers Co-administration of rifampicin with ticagrelor decreased ticagrelor Cmax and AUC by 73% and 86
Eintrag öffnenBrilique · 4.5 · CYP3A inducers Co-administration of rifampicin with ticagrelor decreased ticagrelor Cmax and AUC by 73% and 86
Eintrag öffnen